Danchin N. Improved long-term survival after acute myocardial infarction: the success of comprehensive care from the acute stage to the long term. Eur Heart J. 2023;44:499–501.

Article  PubMed  Google Scholar 

Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: a report from the American heart association. Circulation. 2020;141:e139–e596.

Article  PubMed  Google Scholar 

Zhou M, Liu J, Hao Y, Liu J, Huo Y, Smith SC Jr, et al. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the improving care for cardiovascular disease in China-acute coronary syndrome project. Cardiovasc Diabetol. 2018;17:147.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahtta D, Khalid U, Misra A, Samad Z, Nasir K, Virani SS. Premature atherosclerotic cardiovascular disease: what have we learned recently? Curr Atheroscler Rep. 2020;22:44.

Article  PubMed  Google Scholar 

Guo Q, Miao M, Duan L, Liu Y, Qiu Y, Feng X, et al. The relationship between insulin resistance, serum alkaline phosphatase, and left ventricular dysfunction following myocardial infarction. Sci Rep. 2023;13:17974.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Webster KA. Stress hyperglycemia and enhanced sensitivity to myocardial infarction. Curr Hypertens Rep. 2008;10:78–84.

Article  CAS  PubMed  Google Scholar 

Li T, Wang P, Wang X, Liu Z, Zhang Z, Zhang Y, et al. Inflammation and insulin resistance in diabetic chronic coronary syndrome patients. Nutrients. 2023;15:2808.

Irfan H. Obesity, cardiovascular disease, and the promising role of semaglutide: insights from the SELECT trial. Curr Probl Cardiol. 2024;49:102060.

Article  PubMed  Google Scholar 

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, et al. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7:618–28.

Article  CAS  PubMed  Google Scholar 

Bloomgarden ZT. Measures of insulin sensitivity. Clin Lab Med. 2006;26:611–33.

Article  PubMed  Google Scholar 

DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–23.

CAS  PubMed  Google Scholar 

Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294:E15–26.

Article  CAS  PubMed  Google Scholar 

Khan SH, Sobia F, Niazi NK, Manzoor SM, Fazal N, Ahmad F. Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr. 2018;10:74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetology. 2019;18:150.

Ma XT, Dong LS, Shao QY, Cheng YJ, Lv S, Sun Y, et al. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovasc Diabetol. 2020;19:31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetology. 2020;19:80 .

Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, et al. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Nutr, Metab, Cardiovasc Dis. 2020;30:2351–62.

Article  CAS  PubMed  Google Scholar 

Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19:108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao SD, Ma WJ, Huang SZ, Lin XZ, Yu MY. Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries. Nutr Metab Cardiovasc Dis. 2021;31:3184–92.

Article  CAS  PubMed  Google Scholar 

Yang J, Tang YD, Zheng YT, Li C, Zhou Q, Gao J, et al. The impact of the triglyceride-glucose index on poor prognosis in nondiabetic patients undergoing percutaneous coronary intervention. Front Endocrinol. 2021. https://doi.org/10.3389/fendo.2021.710240.

Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, et al. Predictive effect of triglyceride-glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China. Cardiovasc Diabetol. 2021;20:43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, et al. Triglyceride-glucose index as a surrogate marker of insulin resistance for predicting cardiovascular outcomes in nondiabetic patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary Iintervention. J Atheroscler Thrombosis. 2021;28:1175–94.

Article  CAS  Google Scholar 

Chen L, Ding XH, Fan KJ, Gao MX, Yu WY, Liu HL, et al. Association between triglyceride-glucose index and 2-year adverse cardiovascular and cerebrovascular events in patients with type 2 diabetes mellitus who underwent off-pump coronary artery bypass grafting. Diabetes Metab Syndr Obes-Targets Ther. 2022;15:439–50.

Article  Google Scholar 

Guo JQ, Ji ZJ, Carvalho A, Qian LL, Ji JJ, Jiang Y, et al. The triglycerides-glucose index and the triglycerides to high-density lipoprotein cholesterol ratio are both effective predictors of in-hospital death in non-diabetic patients with AMI. PeerJ. 2022;10:e14346.

Article  PubMed  PubMed Central  Google Scholar 

Saylik F, Çinar T, Selçuk M, Tanboga IH. The predictive value of triglyceride-glucose index for in-hospital and one-year mortality in elderly non-diabetic patients with ST-segment elevation myocardial infarction. J Geriatr Cardiol. 2022;19:610–7.

CAS  PubMed  PubMed Central  Google Scholar 

Shao QY, Ma XT, Yang ZQ, Li QX, Wang YF, Liang J, et al. Prognostic significance of multiple triglycerides-derived metabolic indices in patients with acute coronary syndrome. J Geriatr Cardiol. 2022;19:456–68.

CAS  PubMed  PubMed Central  Google Scholar 

Wu ZG, Liu L, Wang WW, Cui HL, Zhang YR, Xu JC, et al. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovasc Diabetol. 2022;21:142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiong SQ, Chen Q, Chen X, Hou J, Chen YZ, Long Y, et al. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2022;21:145.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu R, Zhao YY, Cui KY, Yang JG, Xu HY, Yin D, et al. Triglyceride glucose index predicts in-hospital mortality in patients with ST-segment elevation myocardial infarction who underwent primary angiography. J Geriatr Cardiol. 2023;20:185–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao Q, Yuanyuan Z, Lijuan C. The prognostic value of the triglyceride glucose index in patients with acute myocardial infarction. J Cardiovasc Pharmacol Ther. 2023. https://doi.org/10.1177/10742484231181846.

Karadeniz F, Sancaktepe EA, Karadeniz Y. High triglyceride-glucose index is associated with poor prognosis in patients with acute coronary syndrome in long-term follow-up. Angiology. 2023;74:139–48.

Article  CAS  PubMed  Google Scholar 

Ye Z, Xu Y, Tang L, Wu M, Wu B, Zhu T, et al. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model. Cardiovasc Diabetol. 2023;22:87.

Zhang Y, Chu C, Zhong Z, Luo YB, Ning FF, Guo N. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents. Front Endocrinol (Lausanne). 2023;14:1101952.

Article  PubMed  Google Scholar 

Zhao XX, Song L, Li JN, Zhou JY, Li N, Yan SD, et al. Effect of triglyceride-glucose indices and circulating PCSK9-associated cardiovascular risk in STEMI patients with primary percutaneous coronary artery disease: a prospective cohort study. J Inflamm Res. 2023;16:269–82.

Article  CAS  PubMed